Edit |   |
---|---|
Antigenic Specificity | Leucine-Rich Repeat Serine/threonine-Protein Kinase 2 (LRRK2) |
Clone | monoclonal |
Host Species | Mouse |
Reactive Species | human, rat |
Isotype | IgG2a |
Format | biotin conjugate |
Size | 100 µg, |
Concentration | 1 mg/ml |
Applications | WB, IF/ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | LRRK2/Dardarin antibody is a Mouse monoclonal against LRRK2. |
Immunogen | Fusion protein amino acids 841-960 of human LRRK2. 81% identical in mouse, 80% identical in rat. <30% identity with LRRK1. |
Other Names | LRRK2, Leucine Rich Repeat Kinase 2, DARDARIN, PARK8, Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2, Parkinson Disease (Autosomal Dominant) 8, Augmented In Rheumatoid Arthritis 17, LRRK2, LRRK2, LRRK2 , LRRK2 , Leucine Rich Repeat Kinase 2, Leucine Rich Repeat Kinase 2, Leucine Rich Repeat Kinase 2 , Leucine Rich Repeat Kinase 2 , DARDARIN, DARDARIN, DARDARIN , DARDARIN , PARK8, PARK8, PARK8 , PARK8 , Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2, Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2, Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2 , Leucine-Rich Repeat Serine/Threonine-Protein Kinase 2 , Parkinson Disease (Autosomal Dominant) 8, Parkinson Disease (Autosomal Dominant) 8, Parkinson Disease (Autosomal Dominant) 8 , Parkinson Disease (Autosomal Dominant) 8 , Augmented In Rheumatoid Arthritis 17, Augmented In Rheumatoid Arthritis 17, Augmented In Rheumatoid Arthritis 17 , Augmented In Rheumatoid Arthritis 17 |
Gene, Accession # | Gene ID: 120892, NCBI: NP_940980, UniProt: Q5S007 |
Catalog # | abx443014 |
Price | please inquire |
Order / More Info | Leucine-Rich Repeat Serine/threonine-Protein Kinase 2 (LRRK2) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950